Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This multicenter randomized controlled clinical trial was conducted to compare the eradication efficacy and health economic benefits of individualized regimens based on HP drug resistance mutation gene detection (multiple PCR method), individualized regimens based on HP traditional drug sensitivity testing (E-test method) and empirical regimens in the Helicobacter pylori treatment.
Epistemonikos ID: cccf282a93ac8d1aaa585045828dd53829d9e72c
First added on: May 10, 2024